Analogues of erectile dysfunction drugs: An under-recognised threat

Hong Kong Medical Journal

Volumn 13, Issue 5, 2007, Pages 359-363

  Poon, W T ^a   Lam, Y H ^a   Lai, C K ^a   Chan, Albert Y W ^a   Mak, Tony W L ^a  

^a PRINCESS MARGARET HOSPITAL   (Hong Kong)

Author keywords

Designer drugs; Impotence; Sildenafil; Vardenafil

Indexed keywords

ACETILDENAFIL; HYDROXYACETILDENAFIL; HYDROXYHOMOSILDENAFIL; NON PRESCRIPTION DRUG; PHOSPHODIESTERASE V INHIBITOR; PIPERIDENAFIL; SILDENAFIL; TADALAFIL; UNCLASSIFIED DRUG; VARDENAFIL;

ADULT; ARTICLE; ATAXIA; CASE REPORT; DRUG INDUCED ATAXIA; DRUG SCREENING; DRUG SURVEILLANCE PROGRAM; ERECTILE DYSFUNCTION; HONG KONG; HUMAN; MALE; TOXICOLOGY;

ADULT; ATAXIA; CARBOLINES; DATA COLLECTION; DRUG CONTAMINATION; DRUGS, NON-PRESCRIPTION; ERECTILE DYSFUNCTION; HONG KONG; HUMANS; IMIDAZOLES; MALE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PLANT PREPARATIONS; PURINES; PYRIMIDINONES; SULFONES; TRIAZINES;

EID: 35548951413     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Fischer J, Ganellin CR. Analogue-based drug discovery. Weinheim: Wiley-VCH; 2006.
2. Tan GH, Rabbino MD, Hopper J Jr. Is phenacetin a nephrotoxin? A report on twenty-three users of the drug. Calif Med 1964;101:73-7.
3. DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. J Health Econ 2003;22:151-85.
4. de Boer D, Bosman I. A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugs. Pharm World Sci 2004;26:110-3.
5. Malvey TC, Armsey TD 2nd. Tetrahydrogestrinone: the discovery of a designer steroid. Curr Sports Med Rep 2005;4:227-30.
6. Wu M, Wang J , Wang S, et al. Identifying N-nitrosofenfluramine in a nutrition supplement. J Chromatogr Sci 2005;43:7-10.
7. Zou P, Oh SS, Hou P, Low MY, Koh HL. Simultaneous determination of synthetic phosphodiesterase-5 inhibitors found in a dietary supplement and pre-mixed bulk powders for dietary supplements using high-performance liquid chromatography with diode array detection and liquid chromatography-electrospray ionization tandem mass spectrometry. J Chromatogr A 2006;1104:113-22.
8. Lai CK, Lee T, Au KM, Chan AY. Uniform solid-phase extraction procedure for toxicological drug screening in serum and urine by HPLC with photodiode-array detection. Clin Chem 1997;43:312-25.
9. Wespes E, Amar E, Hatzichristou D, Montorsi F, Pryor J, Vardi Y; European Association of Urology. Guidelines on erectile dysfunction. Eur Urol 2002;41:1-5.
10. Stief CG, Uckert S, Becker AJ, Truss MC, Jonas U. The effect of the specific phosphodiesterase (PDE) inhibitors on human and rabbit cavernous tissue in vitro and in vivo. J Urol 1998;159:1390-3.
11. Reepmeyer JC, Woodruff JT. Use of liquid chromatographymass spectrometry and a hydrolytic technique for the detection and structure elucidation of a novel synthetic vardenafil designer drug added illegally to a "natural" herbal dietary supplement. J Chromatogr A 2006;1125:67-75.
12. Gratz SR, Gamble BM, Flurer RA. Accurate mass measurement using Fourier transform ion cyclotron resonance mass spectrometry for structure elucidation of designer drug analogs of tadalafil, vardenafil and sildenafil in herbal and pharmaceutical matrices. Rapid Commun Mass Spectrom 2006;20:2317-27.
13. Lai KC, Liu YC, Tseng MC, Lin JH. Isolation and identification of a sildenafil analogue illegally added in dietary supplements. J Food Drug Anal 2006;14:19-23.
14. Campbell S, Qureshi T. Taking Ecstasy...it's child's play! Paediatr Anaesth 2005;15:257-9.
15. Lai V, Smith A, Thorburn D, Raman VS. Severe hepatic injury and adulterated Chinese medicines. BMJ 2006;332:304-5.
16. Lau G, Lo DS, Yao YJ, Leong HT, Chan CL, Chu SS. A fatal case of hepatic failure possibly induced by nitrosofenfluramine: a case report. Med Sci Law 2004;44:252-63.
17. Strom BL. How the US drug safety system should be changed. JAMA 2006;295:2072-5.
18. Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 2001;286:954-9.
19. Kim DK, Young Lee J, Park HJ, Minh Thai K. Synthesis and phosphodiesterase 5 inhibitory activity of new sildenafil analogues containing a phosphonate group in the 5(′)-sulfonamide moiety of phenyl ring. Bioorg Med Chem Lett 2004;14:2099-103.
20. Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995;75:725-48.
21. Yuen YP, Lai CK, Poon WT, Ng SW, Chan AY, Mak TW. Adulteration of over-the-counter slimming products with pharmaceutical analogues - an emerging threat. Hong Kong Med J 2007;13:216-20.
22. Yuan X, Forman BM. Detection of designer steroids. Nucl Recept Signal 2005;3:e002.
23. The Hong Kong Department of Health Press Release 17 November 2006. Hong Kong SAR Government website: http://www.info.gov.hk/gia/general/200611/17/ P200611170307.htm. Accessed 29 Mar 2007.